Ken Fisher’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.34M | Buy |
18,593
+4
| +0% | +$1.15K | ﹤0.01% | 471 |
|
2025
Q1 | $5.73M | Buy |
18,589
+2,250
| +14% | +$694K | ﹤0.01% | 475 |
|
2024
Q4 | $5.77M | Buy |
16,339
+10,034
| +159% | +$3.54M | ﹤0.01% | 486 |
|
2024
Q3 | $2.26M | Buy |
6,305
+1,150
| +22% | +$412K | ﹤0.01% | 567 |
|
2024
Q2 | $1.64M | Buy |
5,155
+334
| +7% | +$106K | ﹤0.01% | 616 |
|
2024
Q1 | $1.11M | Buy |
4,821
+993
| +26% | +$228K | ﹤0.01% | 674 |
|
2023
Q4 | $842K | Buy |
3,828
+209
| +6% | +$46K | ﹤0.01% | 713 |
|
2023
Q3 | $817K | Sell |
3,619
-730
| -17% | -$165K | ﹤0.01% | 780 |
|
2023
Q2 | $960K | Buy |
4,349
+23
| +0.5% | +$5.08K | ﹤0.01% | 783 |
|
2023
Q1 | $969K | Sell |
4,326
-93
| -2% | -$20.8K | ﹤0.01% | 779 |
|
2022
Q4 | $1.23M | Buy |
+4,419
| New | +$1.23M | ﹤0.01% | 735 |
|
2018
Q1 | – | Sell |
-2,649
| Closed | -$392K | – | 822 |
|
2017
Q4 | $392K | Hold |
2,649
| – | – | ﹤0.01% | 682 |
|
2017
Q3 | $310K | Sell |
2,649
-520
| -16% | -$60.9K | ﹤0.01% | 679 |
|
2017
Q2 | $411K | Buy |
3,169
+45
| +1% | +$5.84K | ﹤0.01% | 620 |
|
2017
Q1 | $423K | Hold |
3,124
| – | – | ﹤0.01% | 579 |
|
2016
Q4 | $448K | Hold |
3,124
| – | – | ﹤0.01% | 572 |
|
2016
Q3 | $369K | Buy |
3,124
+32
| +1% | +$3.78K | ﹤0.01% | 606 |
|
2016
Q2 | $341K | Hold |
3,092
| – | – | ﹤0.01% | 605 |
|
2016
Q1 | $357K | Sell |
3,092
-45
| -1% | -$5.2K | ﹤0.01% | 595 |
|
2015
Q4 | $491K | Buy |
3,137
+219
| +8% | +$34.3K | ﹤0.01% | 571 |
|
2015
Q3 | $383K | Buy |
2,918
+468
| +19% | +$61.4K | ﹤0.01% | 574 |
|
2015
Q2 | $426K | Hold |
2,450
| – | – | ﹤0.01% | 468 |
|
2015
Q1 | $422K | Buy |
+2,450
| New | +$422K | ﹤0.01% | 461 |
|